Companies
Surmodics
a publicly traded (Nasdaq: SRDX) coatings and device-technology company offering medical device drug delivery coatings with durable and bioresorbable polymer platforms tunable from minutes-to-years elution,…
- Country
- United States
- Ticker
- SRDX
hydrophilic-coating
us
Coverage
| EU | US | |
|---|---|---|
| diagnostics-medtech | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Production site | Eden Prairie, Minnesota (multiple facilities) | surmodics.gcs-web.com · sec.gov |
| Production site | Ballinasloe, Ireland | surmodics.gcs-web.com · sec.gov |
| Revenue | $126.1M trailing twelve months | stocktitan.net |
| Certification | ISO 13485 (manufacturing facilities in Eden Prairie, MN and Ballinasloe, Ireland) | surmodics.gcs-web.com · sec.gov |
| Certification | ISO 9001 (one manufacturing facility and warehouse facility in Eden Prairie, MN) | surmodics.gcs-web.com · sec.gov |
| Regulatory approval | SurVeil DCB PMA approval (FDA, 2023) and CE mark (2020) | sec.gov · surmodics.com |
Independent sources: sec.gov · stocktitan.net
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Biocompatible coatings for medical devices | diagnostics-medtech | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.